AZN
Price
$70.02
Change
+$0.39 (+0.56%)
Updated
Jul 8 closing price
Capitalization
208.98B
20 days until earnings call
SNY
Price
$48.17
Change
-$0.15 (-0.31%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
122.61B
23 days until earnings call
Interact to see
Advertisement

AZN vs SNY

Header iconAZN vs SNY Comparison
Open Charts AZN vs SNYBanner chart's image
AstraZeneca
Price$70.02
Change+$0.39 (+0.56%)
Volume$4.08M
Capitalization208.98B
Sanofi ADS
Price$48.17
Change-$0.15 (-0.31%)
Volume$38.04K
Capitalization122.61B
AZN vs SNY Comparison Chart in %
Loading...
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZN vs. SNY commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZN is a Hold and SNY is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (AZN: $70.02 vs. SNY: $48.18)
Brand notoriety: AZN: Notable vs. SNY: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AZN: 93% vs. SNY: 110%
Market capitalization -- AZN: $208.98B vs. SNY: $122.61B
AZN [@Pharmaceuticals: Major] is valued at $208.98B. SNY’s [@Pharmaceuticals: Major] market capitalization is $122.61B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZN’s FA Score shows that 1 FA rating(s) are green whileSNY’s FA Score has 1 green FA rating(s).

  • AZN’s FA Score: 1 green, 4 red.
  • SNY’s FA Score: 1 green, 4 red.
According to our system of comparison, AZN is a better buy in the long-term than SNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZN’s TA Score shows that 4 TA indicator(s) are bullish while SNY’s TA Score has 4 bullish TA indicator(s).

  • AZN’s TA Score: 4 bullish, 7 bearish.
  • SNY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SNY is a better buy in the short-term than AZN.

Price Growth

AZN (@Pharmaceuticals: Major) experienced а -2.02% price change this week, while SNY (@Pharmaceuticals: Major) price change was -1.77% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.67%. For the same industry, the average monthly price growth was +0.29%, and the average quarterly price growth was +8.76%.

Reported Earning Dates

AZN is expected to report earnings on Nov 06, 2025.

SNY is expected to report earnings on Oct 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.67% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZN($209B) has a higher market cap than SNY($123B). AZN has higher P/E ratio than SNY: AZN (35.30) vs SNY (20.80). AZN YTD gains are higher at: 8.395 vs. SNY (4.626). AZN has higher annual earnings (EBITDA): 13.4B vs. SNY (12.6B). SNY has more cash in the bank: 8.98B vs. AZN (5.86B). SNY has less debt than AZN: SNY (18.4B) vs AZN (28.6B). SNY (46.4B) and AZN (45.8B) have equivalent revenues.
AZNSNYAZN / SNY
Capitalization209B123B170%
EBITDA13.4B12.6B106%
Gain YTD8.3954.626181%
P/E Ratio35.3020.80170%
Revenue45.8B46.4B99%
Total Cash5.86B8.98B65%
Total Debt28.6B18.4B155%
FUNDAMENTALS RATINGS
AZN vs SNY: Fundamental Ratings
AZN
SNY
OUTLOOK RATING
1..100
6116
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
7
Undervalued
PROFIT vs RISK RATING
1..100
4468
SMR RATING
1..100
4675
PRICE GROWTH RATING
1..100
5959
P/E GROWTH RATING
1..100
8391
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNY's Valuation (7) in the Pharmaceuticals Major industry is in the same range as AZN (24). This means that SNY’s stock grew similarly to AZN’s over the last 12 months.

AZN's Profit vs Risk Rating (44) in the Pharmaceuticals Major industry is in the same range as SNY (68). This means that AZN’s stock grew similarly to SNY’s over the last 12 months.

AZN's SMR Rating (46) in the Pharmaceuticals Major industry is in the same range as SNY (75). This means that AZN’s stock grew similarly to SNY’s over the last 12 months.

AZN's Price Growth Rating (59) in the Pharmaceuticals Major industry is in the same range as SNY (59). This means that AZN’s stock grew similarly to SNY’s over the last 12 months.

AZN's P/E Growth Rating (83) in the Pharmaceuticals Major industry is in the same range as SNY (91). This means that AZN’s stock grew similarly to SNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZNSNY
RSI
ODDS (%)
Bearish Trend 1 day ago
55%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
52%
Bearish Trend 2 days ago
45%
Momentum
ODDS (%)
Bearish Trend 1 day ago
49%
Bullish Trend 2 days ago
55%
MACD
ODDS (%)
Bearish Trend 1 day ago
50%
Bullish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 2 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
45%
Bearish Trend 2 days ago
41%
Advances
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 7 days ago
51%
Declines
ODDS (%)
Bearish Trend 6 days ago
45%
Bearish Trend 21 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
40%
Bullish Trend 2 days ago
56%
Aroon
ODDS (%)
Bullish Trend 1 day ago
41%
Bearish Trend 2 days ago
43%
View a ticker or compare two or three
Interact to see
Advertisement
AZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PXI43.710.57
+1.32%
Invesco Dorsey Wright Energy MomentumETF
NXP14.010.01
+0.07%
Nuveen Select Tax-Free
SHPP27.75N/A
N/A
Pacer Industrials and Logistics ETF
IWY246.56-0.25
-0.10%
iShares Russell Top 200 Growth ETF
SIXL36.48-0.33
-0.91%
ETC 6 Meridian Low Beta Eq Strat ETF

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with SNYNF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then SNYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
+0.04%
SNYNF - SNY
61%
Loosely correlated
-1.69%
GSK - SNY
52%
Loosely correlated
+0.03%
NVS - SNY
48%
Loosely correlated
+0.18%
PFE - SNY
46%
Loosely correlated
-0.55%
AZN - SNY
46%
Loosely correlated
+0.26%
More